GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 744 filers reported holding GLAXOSMITHKLINE PLC in Q3 2017. The put-call ratio across all filers is 0.96 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $5,640,000 | +10.5% | 148,855 | +37.0% | 0.01% | +42.9% |
| Q4 2019 | $5,106,000 | -11.6% | 108,670 | -19.7% | 0.01% | -22.2% |
| Q3 2019 | $5,773,000 | +2.4% | 135,269 | -3.9% | 0.01% | +12.5% |
| Q2 2019 | $5,635,000 | -6.2% | 140,806 | -2.1% | 0.01% | -11.1% |
| Q1 2019 | $6,008,000 | +9.4% | 143,765 | +0.1% | 0.01% | -10.0% |
| Q4 2018 | $5,490,000 | -8.5% | 143,682 | -3.8% | 0.01% | +11.1% |
| Q3 2018 | $6,000,000 | +1.6% | 149,376 | +1.9% | 0.01% | 0.0% |
| Q2 2018 | $5,908,000 | +4.9% | 146,562 | +1.7% | 0.01% | 0.0% |
| Q1 2018 | $5,630,000 | +457.4% | 144,105 | +406.3% | 0.01% | +800.0% |
| Q4 2017 | $1,010,000 | -32.0% | 28,461 | -22.2% | 0.00% | -50.0% |
| Q3 2017 | $1,486,000 | -0.3% | 36,600 | +5.9% | 0.00% | 0.0% |
| Q2 2017 | $1,490,000 | +10.9% | 34,546 | +8.5% | 0.00% | 0.0% |
| Q1 2017 | $1,343,000 | +3.0% | 31,848 | -5.9% | 0.00% | 0.0% |
| Q4 2016 | $1,304,000 | -17.5% | 33,860 | -7.7% | 0.00% | -33.3% |
| Q3 2016 | $1,581,000 | +8.7% | 36,667 | +1.9% | 0.00% | 0.0% |
| Q2 2016 | $1,455,000 | -2.2% | 35,971 | -2.2% | 0.00% | 0.0% |
| Q1 2016 | $1,488,000 | -65.0% | 36,775 | -65.1% | 0.00% | -62.5% |
| Q4 2015 | $4,248,000 | -3.3% | 105,281 | -7.9% | 0.01% | -11.1% |
| Q3 2015 | $4,394,000 | +187.6% | 114,266 | +253.6% | 0.01% | +200.0% |
| Q2 2015 | $1,528,000 | +3.5% | 32,312 | +3.5% | 0.00% | 0.0% |
| Q1 2015 | $1,477,000 | -22.4% | 31,225 | -29.9% | 0.00% | 0.0% |
| Q4 2014 | $1,903,000 | +65.5% | 44,526 | +78.0% | 0.00% | +50.0% |
| Q3 2014 | $1,150,000 | -46.5% | 25,019 | -37.8% | 0.00% | -50.0% |
| Q2 2014 | $2,150,000 | +0.6% | 40,193 | +0.4% | 0.00% | 0.0% |
| Q1 2014 | $2,138,000 | -1.3% | 40,023 | -1.3% | 0.00% | 0.0% |
| Q4 2013 | $2,166,000 | +4.1% | 40,565 | -2.2% | 0.00% | 0.0% |
| Q3 2013 | $2,080,000 | -27.6% | 41,468 | -27.8% | 0.00% | -33.3% |
| Q2 2013 | $2,871,000 | – | 57,447 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
| Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
| Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
| Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
| P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
| Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
| Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
| Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
| Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
| JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |